[{"Assets_0_Q3_USD":"4695254000.0","CIK":"1048477","CommonStockSharesConverted_0_Q3_shares":"177902788.0","CommonStockSharesOutstanding_0_Q3_shares":"177902788.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.07","EarningsPerShareBasic_3_Q3_USD":"-0.42","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-29166000.0","NetIncomeLoss_1_Q3_USD":"-12620000.0","NetIncomeLoss_3_Q3_USD":"-73561000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q3_USD":"391706000.0","RevenuesConverted_3_Q3_USD":"1137998000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"2914945000.0","Ticker":"BMRN","filed":"20181026","footnote":null,"form":"10-Q","fp":"Q3","fy":"2018.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20180930","qtrs":"0","uom":"USD"}]